A detailed history of Gilbert & Cook, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Gilbert & Cook, Inc. holds 1,743 shares of LLY stock, worth $1.3 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares
1,743
Previous 1,757 0.8%
Holding current value
$1.3 Million
Previous $1.59 Million 2.89%
% of portfolio
0.22%
Previous 0.24%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$772.14 - $960.02 $10,809 - $13,440
-14 Reduced 0.8%
1,743 $1.54 Million
Q1 2024

May 02, 2024

BUY
$592.2 - $792.28 $5,329 - $7,130
9 Added 0.51%
1,757 $1.37 Million
Q4 2023

Feb 05, 2024

SELL
$525.19 - $619.13 $42,540 - $50,149
-81 Reduced 4.43%
1,748 $1.02 Million
Q3 2023

Nov 02, 2023

SELL
$434.7 - $599.3 $640,747 - $883,368
-1,474 Reduced 44.63%
1,829 $982,000
Q2 2023

Aug 14, 2023

SELL
$350.74 - $468.98 $158,885 - $212,447
-453 Reduced 12.06%
3,303 $1.55 Million
Q1 2023

May 05, 2023

SELL
$310.63 - $364.82 $170,535 - $200,286
-549 Reduced 12.75%
3,756 $1.29 Million
Q4 2022

Feb 09, 2023

SELL
$321.55 - $374.67 $46,946 - $54,701
-146 Reduced 3.28%
4,305 $1.57 Million
Q3 2022

Nov 03, 2022

BUY
$296.48 - $337.87 $75,898 - $86,494
256 Added 6.1%
4,451 $1.58 Million
Q2 2022

Aug 05, 2022

SELL
$278.73 - $327.27 $213,785 - $251,016
-767 Reduced 15.46%
4,195 $1.36 Million
Q1 2022

May 02, 2022

BUY
$234.69 - $291.66 $123,212 - $153,121
525 Added 11.83%
4,962 $1.42 Million
Q4 2021

Jan 19, 2022

BUY
$224.85 - $279.04 $136,708 - $169,656
608 Added 15.88%
4,437 $1.23 Million
Q3 2021

Jan 20, 2022

BUY
$221.6 - $272.71 $767,400 - $944,394
3,463 Added 946.17%
3,829 $885,000
Q3 2021

Oct 13, 2021

SELL
$221.6 - $272.71 $494,832 - $608,961
-2,233 Reduced 85.92%
366 $885,000
Q2 2021

Jul 13, 2021

SELL
$180.55 - $233.54 $326,795 - $422,707
-1,810 Reduced 41.05%
2,599 $597,000
Q1 2021

Apr 14, 2021

BUY
$164.32 - $212.72 $54,554 - $70,623
332 Added 8.14%
4,409 $824,000
Q4 2020

Feb 11, 2021

BUY
$130.46 - $172.63 $172,337 - $228,044
1,321 Added 47.93%
4,077 $687,000
Q3 2020

Nov 13, 2020

BUY
$146.22 - $169.13 $16,522 - $19,111
113 Added 4.28%
2,756 $408,000
Q2 2020

Aug 05, 2020

BUY
$136.42 - $164.18 $114,319 - $137,582
838 Added 46.43%
2,643 $434,000
Q1 2020

May 05, 2020

BUY
$119.05 - $147.35 $6,547 - $8,104
55 Added 3.14%
1,805 $250,000
Q4 2019

Feb 03, 2020

BUY
$106.92 - $132.43 $187,110 - $231,752
1,750 New
1,750 $230,000
Q2 2019

Aug 05, 2019

SELL
$110.79 - $129.32 $184,908 - $215,835
-1,669 Closed
0 $0
Q1 2019

May 10, 2019

BUY
$111.31 - $131.02 $185,776 - $218,672
1,669 New
1,669 $216,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $711B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Gilbert & Cook, Inc. Portfolio

Follow Gilbert & Cook, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gilbert & Cook, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Gilbert & Cook, Inc. with notifications on news.